Root Financial Partners
AMRX icon

Root Financial Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Root Financial Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.5K Buy
+623
New +$11.2K ﹤0.01% 1798
2026
Q2 		– Sell
-362
Closed -$4.5K – 540
2026
Q1 		$4.5K Buy
362
+23
+7% +$309 ﹤0.01% 1990
2025
Q4 		$4.27K Buy
339
+135
+66% +$1.54K ﹤0.01% 1810
2025
Q3 		$2.04K Buy
+204
New +$1.83K ﹤0.01% 1952

Other funds holding AMRX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Root Financial Partners's AMRX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 623 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #1798 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in AMRX as recently as Q1 2026.

Root Financial Partners first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Root Financial Partners held 623 shares of Amneal Pharmaceuticals worth $12.5K as of Q3 2026.
  • Amneal Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #1798 holding.
  • Root Financial Partners first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.